Skip to content
Amour Fund

Amour Fund

Amour Science Foundation

  • About
  • Research
    • Clinical Trials
    • Research Papers
    • Mouse Model
  • Resources
    • CDG Clinics
    • CDG Map
  • COVID-19
    • Statement
    • Guidance
    • Recommendations
    • Video
  • CDG Children’s Book
  • CDG Registry
  • Patient Registry

Research Papers

Existing PMM2-Related Research Papers

Sorbitol is a-severity biomarker for PMM2 CDG with therapeutic implications
D-galactose supplementation in individuals with PMM2-CDG
Should patients with PMM2-CDG be screened for adrenal insufficiency
Towards a therapy for PMM2 Deficiency
Socio-emotional Problems in Children with CDG
Pharmacological-Chaperoning-A-Potential-Treatment
Nutritional Therapies in CGDC
Successful prenatal mannose treatment for PMM2-CDG in mice
Mutations in PMM2 That Cause CDG
CDG and Their Impact on the Endocrine System
29 French adult patients with PMM2-CDG
Therapy for Growth Failure and IGF-1 Deficiency in PMM2-CDG
Lack of Homozygotes for the Most Frequent Disease Allele in PMM2
PMM2-CDG in a macrosomic 16-month-old boy
IGF system in children with congenital disorders of glycosylation
Insights into complexity of congenital disorders of glycosylation
Towards a therapy for phosphomannomutase 2 deficiency
Expanding the Spectrum of PMM2-CDG Phenotype
Exogenous mannose does not raise steady state mannose-6-phosphate
High Residual Activity of PMM2 in Patients’ Fibroblasts
The Molecular Landscape of PMM2 Deficiency in Iberian Peninsula

© 2024 Amour Science Foundation is a tax-exempt 501(c)(3) non-profit organization Federal Tax ID Number: 87-2127837

Contact US

(626) 376-7420
info@AmourFund.org

SIGN UP FOR OUR NEWSLETTER

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Email
Proudly powered by WordPress